Ignite Creation Date:
2024-05-05 @ 10:37 PM
Last Modification Date:
2024-10-26 @ 10:21 AM
Study NCT ID:
NCT01144221
Status:
TERMINATED
Last Update Posted:
2018-04-09
First Post:
2010-06-14
Brief Title:
Bone Marrow Derived Mononuclear Cells for Ischemic Cardiomyopathy
Sponsor:
Kai Jaquet PhD DSc
Organization:
Asklepios proresearch
Study Overview
Official Title:
Protocol on an Evaluative Study on Bone Marrow Derived Mononuclear Cells for Optimization of Biventricular Pacing in Patients With Chronic Ischemic Left Ventricular Dysfunction
Status:
TERMINATED
Status Verified Date:
2012-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
funding issues
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Alster-Star
Brief Summary:
This is an evaluative monocentric study in patients with chronic ischemic heart disease and left bundle branch block who received an ICD-CRT It is an early investigation on the safety and effects of a single administration of bone marrow derived mononuclear cells after implantation of an ICD-CRT device as an adjunct to CRT and usual drug treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2008-008368-28 | EUDRACT_NUMBER | None | None |